A recent study published in the Annals of Internal Medicine found that one sixth of patients admitted to a hospital for revascularization for Peripheral Artery Disease (PAD) were readmitted to the hospital within 30 days. Primary reasons were complications, sepsis, and diabetes. The study involved 1,085 US acute care hospitals, covering 61,969 Read more…
In a study published in the European Journal of Preventive Cardiology, results indicated that patients with heart disease were hospitalized less if they walked at a faster pace. This study was based on results of 1,078 hypertensive patients, of whom 85% also had coronary heart disease and 15% also had heart valve disease. At the Read more…
Be sure to visit the SureFit booth, #9, to discover what’s new with PADnet 4.0. PADnet is a critical tool to non-invasively identify peripheral vascular disease. Team with SureFit and PADnet and: Streamline clinical operations via bi-directional HL7 interfaces Save limbs and lives by identifying a chronic condition that affects the 25% Read more…
The newest device for front-line PAD diagnostics PADnet 4.0, performs tests faster, is more secure, and is more portable than ever. PADnet enables medical staff familiar with using a blood pressure cuff to generate valuable diagnostic data, including ABIs, TBIs, and PVRs – even detecting venous reflux disease. What’s new Read more…
Visit the SureFit booth, #419, to discover what’s new with PADnet 4.0. PADnet is a critical tool to help non-invasively identify peripheral vascular disease. Team with SureFit and PADnet to: Save limbs and save lives by identifying a chronic condition that affects 1 in 3 diabetics over the age of Read more…
Going to DERMfoot 2018? Then look forward to experiencing PADnet 4.0 at the SureFit Booth If you are going to be at the DERMfoot 2018 meeting, stop by the SureFit booth [Booth #F9] to discover all that is new with PADnet 4.0 at the upcoming DERMfoot 2018 conference. PADnet is Read more…